Vaccine booster after Johnson & Johnson-Janssen priming are safe and immunogenic
1. Both the Johnson & Johnson-Janssen (JJJ) and mRNA boosters provided an acceptable safety...
Read MoreMar 23, 2022
1. Both the Johnson & Johnson-Janssen (JJJ) and mRNA boosters provided an acceptable safety...
Read MoreMar 23, 2022
1. In this prospective cohort study neonatal hypoglycemia was not significantly associated with...
Read MoreMar 23, 2022
1. This study found minorities are diagnosed with opioid use disorder on average 37 days later...
Read MoreMar 23, 2022
1. mRNA booster vaccines for Covid-19 were highly effective against delta infection but less...
Read MoreMar 21, 2022
1. Preliminary data from a convenience sample of kratom users noted that current kratom use...
Read MoreMar 21, 2022
1. Hospitalized Covid-19 patients presenting from socially vulnerable neighborhoods had greater...
Read MoreMar 17, 2022
1. About 1 in 7 cases of screen-detected cancer is overdiagnosed in the US population. 2. The rate...
Read MoreMar 17, 2022
1. A retrospective analysis found that 29% of youth with benzodiazepine overdose and 25% of youth...
Read MoreMar 17, 2022
1. This systematic review and meta-analysis found a modest absolute risk reduction of 0.8% in...
Read MoreMar 17, 2022
1. In patients with hepatitis C virus who recently injected drugs, 67% in the accessible care arm...
Read MoreMar 17, 2022
1. For children with non-severe tuberculosis, 4 months of antituberculosis treatments was...
Read MoreMar 17, 2022
1. This systematic review and meta-analysis demonstrated that low- and no-calorie sweetened...
Read MoreMar 16, 2022
1. In a retrospective cohort of about 11,000 children with at least one blood lead level above 4...
Read MoreMar 16, 2022
1. Three Covid-19 vaccines from Pfizer, Moderna, and Johnson & Johnson provided durable...
Read MoreMar 11, 2022
1. In this randomized controlled trial, combined treatment with varenicline and nicotine patch...
Read MoreMar 9, 2022
1. Melioidosis, caused by Burkholderia pseudomallei, is rarely diagnosed in the US, and patients...
Read MoreMar 9, 2022
1. Provision of an inhaled glucocorticoid and instruction on its use led to a significantly lower...
Read MoreMar 8, 2022
1. Guidelines changes to frequently used outpatient evaluation and management (E/M) billing use...
Read MoreMar 8, 2022
1. The AD26.COV2.S vaccine provided protection against moderate to severe-critical Covid-19. 2....
Read MoreMar 4, 2022
1. The Novavax vaccine provided high efficacy for the prevention of Covid-19. 2. The Novavax...
Read More